MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma
Y Zhai, A Iura, S Yeasmin, A B Wiese, R Wu, Y Feng, E R Fearon and K R Cho
- DOI:
http://dx.doi.org/doi:10.1038/onc.2011.123
November 2011 - Volume 22 - Issue 10 - p 978–985
doi:
- DOI:
http://dx.doi.org/10.1097/CAD.0b013e32834ac8fc
Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growth
Hilliard, Tyvette S.; Gaisina, Irina N.; Muehlbauer, Amanda G.; Gaisin, Arsen M.; Gallier, Franck; Burdette, Joanna E.
Код: Выделить всё
http://journals.lww.com/anti-cancerdrugs/Abstract/2011/11000/Glycogen_synthase_kinase_3__inhibitors_induce.4.aspxJiansong Fang, Dane Huang, Wenxia Zhao, Hu Ge, Hai-Bin Luo, and Jun Xu
J. Chem. Inf. Model., 2011, 51 (6), pp 1431–1438
DOI:
- DOI:
http://dx.doi.org/10.1021/ci2001154
Shiv K. Singh, Sandra Baumgart, Garima Singh, Alexander O. König, Kristina Reutlinger, Lorenz C. Hofbauer, Peter Barth, Thomas M. Gress, Gwen Lomberk, Raul Urrutia, Martin E. Fernandez-Zapico and Volker Ellenrieder
First Published on May 31, 2011, doi:
- DOI:
http://dx.doi.org/10.1074/jbc.M110.197533
5. Glycogen Synthase Kinase-3β (GSK3β) Negatively Regulates PTTG1/Human Securin Protein Stability, and GSK3β Inactivation Correlates with Securin Accumulation in Breast Tumors
Mar Mora-Santos, M. Cristina Limón-Mortés, Servando Giráldez, Joaquín Herrero-Ruiz, Carmen Sáez, Miguel Á. Japón, Maria Tortolero and Francisco Romero
First Published on July 11, 2011, doi:
- DOI:
http://dx.doi.org/10.1074/jbc.M111.232330
Спасибо!